What it has not had enough of is organized follow-up, adverse-event tracking, protocol discipline, and aggregated real-world reporting
When examining cagrilintide dosing strategies, researchers have found that the 2.4 mg weekly dose offers an optimal balance between efficacy and tolerability in many study populations
Its benefits include: Inhibiting pro-inflammatory cytokines, which is beneficial for Crohns disease, ulcerative colitis, and autoimmune disorders
Gordon found a wealth of published literature suggesting that traumatic brain injury causes pituitary dysfunction, confirming his initial hunch.1 Although the figures vary between studies, at least 50% (and up to 76%) of traumatic brain injury victims show some loss of pituitary hormone function immediately after the brain injury.2-4 In general, the more severe the original brain injury, the more profound the hormonal deficits, although hormone deficiency or insufficiency (levels in the low "normal" range) are seen even in patients with mild traumatic brain injury.5-9 And while about 58% of patients recover their normal pituitary function within one year of their head injury, a shocking 52% develop new pituitary hormone deficiencies after one year
